S&P 500 7,387.05 â–ŧ 197.26 (-2.60%) DOW 50,877.30 â–ŧ 684.63 (-1.33%) NASDAQ 25,726.49 â–ŧ 1,104.47 (-4.12%) US Markets Closed â€ĸ 01:14 AM ET

AFJK

Aimei Health Technology Co., Ltd

Price Chart
Latest Quote

$40.40

-0.01 (-0.02%)
Current Price
Previous Close $40.41
Open $40.40
Day High $40.40
Day Low $40.40
Volume 724
Fetched: 2026-06-06T05:14:17
Stock Information
Shares Outstanding 3.17M
Total Debt $2.02M
Cash Equivalents $3K
Net Income $1.06M
Sector Financial Services
Industry Shell Companies
Market Cap $127.92M
P/E Ratio 237.65
EPS (TTM) $0.17
Exchange NGM
📊 Comprehensive Analysis
Company Data
Enterprise Value$129.94M
Income$1.06M
Book/sh$-1.28
Cash/sh$0.00
Financial Ratios
Quick Ratio0.00
Current Ratio0.00
EPS Growth TTM-77.90%
Returns & Margins
ROA-1.22%
Ownership
Insider Ownership64.96%
Institutional Ownership36.45%
Insider & Institutional transactions data not available
Valuation Ratios
P/B-31.51
Analyst Data
Recommendationnone
Technical Indicators
SMA20$41.50
SMA50$40.94
SMA200$30.81
RSI48.54
ATR2.6893
Shares Float1.44M
Short Float0.24%
Short Ratio0.34
Volatility0.23
Rel Volume0.26
Performance History
Week-3.81%
Month-10.90%
Quarter+34.40%
6 Months+393.89%
YTD-46.74%
Year+262.82%
10 Years+298.03%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-05 $40.40 700
2026-06-04 $40.41 1,000
2026-06-03 $40.87 800
2026-06-02 $43.00 1,600
2026-06-01 $40.00 1,900
2026-05-29 $42.00 2,200
2026-05-28 $41.52 1,100
2026-05-27 $45.32 1,300
2026-05-26 $40.00 2,400
2026-05-22 $40.06 5,800
2026-05-21 $40.50 6,200
2026-05-20 $42.17 10,300
2026-05-19 $41.60 0
2026-05-18 $41.60 6,800
2026-05-15 $41.00 2,500
2026-05-14 $40.20 1,800
2026-05-13 $41.15 1,500
2026-05-12 $42.49 1,100
2026-05-11 $43.00 3,200
2026-05-08 $42.67 2,000
2026-05-07 $45.34 0
2026-05-06 $45.34 1,900
About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31
Revenue
Total Revenue $0 $0
Operating Revenue $0 $0
Expenses
Total Expenses $835,759 $1,064,786
Net Non Operating Interest Income Expense $1,895,527 $3,617,001
Operating Expense $835,759 $1,064,786
General And Administrative Expense $835,759 $1,064,786
Other Operating Expenses - $1,064,786
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $1,059,768 $2,552,215
Net Interest Income $1,895,527 $3,617,001
Interest Income $1,895,527 $3,617,001
Normalized Income $1,059,768 $2,552,215
Net Income From Continuing And Discontinued Operation $1,059,768 $2,552,215
Total Operating Income As Reported $-835,759 $-1,064,786
Net Income Common Stockholders $1,059,768 $2,552,215
Net Income $1,059,768 $2,552,215
Net Income Including Noncontrolling Interests $1,059,768 $2,552,215
Net Income Continuous Operations $1,059,768 $2,552,215
Pretax Income $1,059,768 $2,552,215
Interest Income Non Operating $1,895,527 $3,617,001
Operating Income $-835,759 $-1,064,786
Per Share
Diluted EPS - $0.28
Basic EPS - $0.28
Other
Tax Effect Of Unusual Items $0 $0
Tax Rate For Calcs $0 $0
Normalized EBITDA (Bullshit earnings) $-835,759 $-1,064,786
EBITDA (Bullshit earnings) $-835,759 $-1,064,786
EBIT $-835,759 $-1,064,786
Diluted NI Availto Com Stockholders $1,059,768 $2,552,215
Selling General And Administration $835,759 $1,064,786
Other Gand A $835,759 $1,064,786
Diluted Average Shares - $9,026,000
Basic Average Shares - $9,026,000
Fetched: 2026-06-02
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31
Assets
Net Tangible Assets $8,041,379 $72,307,939 $69,755,724
Total Assets $12,103,039 $73,814,933 $70,470,565
Total Non Current Assets $12,100,110 $73,784,549 $69,889,848
Other Non Current Assets $12,100,110 $73,784,549 $69,889,848
Current Assets $2,929 $30,384 $580,717
Prepaid Assets $0 $2,176 $0
Cash Cash Equivalents And Short Term Investments $2,929 $28,208 $580,717
Cash And Cash Equivalents $2,929 $28,208 $580,717
Cash Financial $2,929 $28,208 $580,717
Debt
Net Debt $2,021,133 $199,492 -
Total Debt $2,024,062 $227,700 -
Current Debt And Capital Lease Obligation $2,024,062 $227,700 -
Current Debt $2,024,062 $227,700 -
Other Current Borrowings $2,024,062 $227,700 -
Liabilities
Total Liabilities Net Minority Interest $4,061,660 $1,506,994 $714,841
Total Non Current Liabilities Net Minority Interest $690,000 $690,000 $690,000
Tradeand Other Payables Non Current $690,000 $690,000 $690,000
Current Liabilities $3,371,660 $816,994 $24,841
Payables And Accrued Expenses $1,347,598 $589,294 $24,841
Payables $899,601 $289,780 -
Non Current Deferred Liabilities - $690,000 $690,000
Equity
Common Stock Equity $8,041,379 $72,307,939 $69,755,724
Total Equity Gross Minority Interest $8,041,379 $72,307,939 $69,755,724
Stockholders Equity $8,041,379 $72,307,939 $69,755,724
Retained Earnings $-4,058,944 $-1,476,823 $-134,337
Other
Ordinary Shares Number $3,166,332 $9,026,000 $9,026,000
Share Issued $3,166,332 $9,026,000 $9,026,000
Tangible Book Value $8,041,379 $72,307,939 $69,755,724
Invested Capital $10,065,441 $72,535,639 $69,755,724
Working Capital $-3,368,731 $-786,610 $555,876
Total Capitalization $8,041,379 $72,307,939 $69,755,724
Capital Stock $12,100,323 $73,784,762 $69,890,061
Common Stock $12,100,323 $73,784,762 $69,890,061
Current Accrued Expenses $447,997 $299,514 $24,841
Dueto Related Parties Current $899,601 $289,780 $0
Additional Paid In Capital - - $0
Fetched: 2026-06-02
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31
Free Cash Flow
Free Cash Flow $-565,100 $-672,289
Operating Activities
Operating Cash Flow $-565,100 $-672,289
Cash Flow From Continuing Operating Activities $-565,100 $-672,289
Investing Activities
Investing Cash Flow $63,579,966 $-277,700
Cash Flow From Continuing Investing Activities $63,579,966 $-277,700
Net Other Investing Changes $63,579,966 $-277,700
Financing Activities
Repurchase Of Capital Stock $-65,326,328 $0
Financing Cash Flow $-63,040,145 $397,480
Cash Flow From Continuing Financing Activities $-63,040,145 $397,480
Net Other Financing Charges $539,821 $119,780
Net Common Stock Issuance $-65,326,328 $0
Issuance Of Capital Stock - $0
Common Stock Issuance - $0
Other
Issuance Of Debt $1,746,362 $277,700
End Cash Position $2,929 $28,208
Beginning Cash Position $28,208 $580,717
Changes In Cash $-25,279 $-552,509
Common Stock Payments $-65,326,328 $0
Net Issuance Payments Of Debt $1,746,362 $277,700
Net Short Term Debt Issuance $1,746,362 $277,700
Short Term Debt Issuance $1,746,362 $277,700
Change In Working Capital $270,659 $392,497
Change In Payables And Accrued Expense $268,483 $394,673
Change In Accrued Expense $148,483 $274,673
Change In Payable $120,000 $120,000
Change In Prepaid Assets $2,176 $-2,176
Other Non Cash Items $-1,895,527 $-3,617,001
Net Income From Continuing Operations $1,059,768 $2,552,215
Repayment Of Debt - $0
Short Term Debt Payments - $0
Fetched: 2026-06-02